Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) can prolong apnoea time in adults. Therefore, THRIVE used for pre-oxygenation in rapid sequence induction of anaesthesia could extend safe apnoea time during prolonged laryngoscopy and intubation. In this randomised controlled trial, we compared the lowest peripheral oxygen saturation (SpO 2 ) during intubation when pre-oxygenating with either traditional facemask or THRIVE. Eighty adult patients, undergoing rapid sequence induction of anaesthesia for emergency surgery, were randomly allocated to pre-oxygenation with 100% oxygen with facemask or with THRIVE. Median (IQR [range]) lowest SpO 2 until 1 min after intubation was 99% (97-100 [70-100]%) for the facemask group vs. 99% (99-100 [96-100]%) for the THRIVE group (p = 0.097). Five patients (12.5%) desaturated below 93% when pre-oxygenated with the facemask vs. none in the THRIVE group (p = 0.019). There were no differences in intubation time or apnoea time between the groups. Median intubation time was 51 (34-66 [22-261]) s in the facemask group vs. 48 (38-63 [10-146]) s in the THRIVE group (p = 0.99). Median apnoea time was 109 (86-142 [37-291]) s and 116 (92-146 [63-249]) s when using facemask and THRIVE, respectively (p = 0.49). No signs of regurgitation of gastric content were detected. The data on desaturation indicate potential benefits of oxygenation with THRIVE for rapid sequence induction compared with facemask pre-oxygenation.
Introduction
Hypoxia at induction of anaesthesia still remains a significant problem and can have a dramatic impact on outcome [1, 2] . To prevent hypoxia during anaesthesiainduced apnoea, pre-oxygenation with 100% oxygen is standard practice before induction [3, 4] . The goal with pre-oxygenation is to extend the time to desaturation by replacing nitrogen with oxygen and increase oxygen stores [5, 6] . The importance of pre-oxygenation is emphasised during rapid sequence induction (RSI) when the patient relies on oxygen stores to maintain oxygenation [6] .
Oxygen administered nasally with prongs or a catheter during intubation increases the time to desaturation [7] [8] [9] and lowers the incidence of hypoxia during intubation [7, [10] [11] [12] . Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE), with an oxygen flow of 40-70 l.min
À1
, has been used as a new technique of oxygenation when securing the difficult airway [13] and in patients undergoing laryngeal surgery [14] . In these studies, a median (range) apnoea time of 14 (5-65) min and mean (SD) apnoea time of 22.5 (4.5) min, respectively, was recorded [13, 14] . No patient in these studies desaturated below 90%.
Transnasal humidified rapid-insufflation ventilatory exchange has potential in pre-oxygenation for RSI anaesthesia since it provides continuous oxygen flow throughout the entire intubation procedure. Hypoxia might thereby be prevented during prolonged apnoea, which can occur when securing a difficult airway [15] . Recently, Mir et al. [16] randomly allocated 40 patients undergoing pre-oxygenation for RSI to either THRIVE or facemask but found no difference in arterial PO 2 . However, the intubation and apnoea times were longer in the THRIVE group making comparison difficult. We wished to repeat the broad approach of Mir et al., but assess the relative declines in oxygen saturation over time with the two techniques.
Methods
This study was approved by the Regional Ethics Committee on Human Research at Karolinska Institute, Stockholm, Sweden. The trial was conducted at the Function Unit, Trauma and Emergency Surgery, Department of Peri-operative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
Adult patients (> 18 years) who required RSI of anaesthesia for emergency surgery during daytime hours were consecutively enrolled after written informed consent during the pre-operative anaesthetic evaluation. Exclusion criteria were body mass index (BMI) > 35 kg.m
À2
, pregnancy, a need for non-invasive ventilation to maintain oxygenation, or inability to give consent. Participants were randomly assigned in a 1:1 ratio in block sizes of 10. Randomisation was performed electronically before the start of the study using www.randomization.com and was not concealed.
Patients were placed supine with the head elevated approximately 25°. An intravenous line was placed and Ringer's acetate solution (Baxter Viaflo, Baxter Medical AB, Kista, Sweden) was given peri-operatively. Standard peri-operative monitoring including electrocardiogram (ECG), non-invasive blood pressure (NIBP) and a pulse oximeter was applied. Peripheral oxygen saturation (SpO 2 ) and end-tidal carbon dioxide (ETCO 2 ) were first recorded when breathing room air (Aisys â Carestation, GE Healthcare, Waukesha, WI, USA or FLOW-i â , Maquet Critical Care AB, Solna, Sweden). If oxygen treatment had been initiated before arrival in the operating theatre, SpO 2 with oxygen added to inspired air was noted. End-tidal carbon dioxide (ETCO 2 ) was measured via a tight occluding facemask on room air before the start of pre-oxygenation and during the first breath after intubation. Patient characteristics, including the reason for and type of surgery, were recorded, as well as: the pre-operative airway evaluation; number of attempts at intubation; need for special airway equipment other than a Macintosh laryngoscope size 3; Cormack-Lehane laryngoscopy grade; and signs of gastric regurgitation in the pharynx while intubating.
Pre-oxygenation according to the randomisation plan took place either with the traditional facemask or with THRIVE for a minimum of 3 min. Traditional facemask pre-oxygenation was done breathing 100% oxygen with a tightly held facemask and a fresh gas flow of 10 l.min À1 delivered via a circle system [4, 17, 18] . When using THRIVE (Optiflow TM , Fisher and Paykel Healthcare, Auckland, New Zealand), a flow of 40 l.min À1 with heated and humidified 100% oxygen via a nasal cannula was delivered. The flow was increased to 70 l.min À1 at apnoea and the nasal cannula was left in place through the entire intubation procedure. Airway patency was carefully maintained using a chin lift or jaw thrust. Rapid sequence induction of anaesthesia was performed according to current practice [3, 17] with drugs chosen and titrated by the anaesthetist in charge. Laryngoscopy was initiated 45-60 s after administration of the neuromuscular blocking agent [19] [20] [21] [22] .
Apnoea time was defined from start of apnoea, assessed visually and when the capnography trace disappeared trace using end-tidal monitoring when a facemask was used, until the first breath with the tracheal tube in place, verified by capnography. If a drop in SpO 2 made manual ventilation necessary during the intubation procedure, this was recorded as the end of apnoea.
Intubation time was defined as the time from the start of laryngoscopy, when the blade was introduced between the teeth, until the first breath with the tracheal tube in place, verified by capnography.
The lowest SpO 2 was measured from anaesthesia induction until 1 min after intubation whereafter the protocol was ended. Rescue manoeuvres, such as interrupting apnoea due to desaturation, were recorded. Patients were followed-up postoperatively to evaluate their subjective level of discomfort when using either facemask or THRIVE, graded by a modified visual analogue scale (VAS), ranging from 0 to 10, where 0 is no discomfort and 10 is maximum discomfort. After follow-up, participation in the study was concluded.
To determine sample size, we estimated the primary outcome parameter, the lowest SpO 2 , partly based on previous reports in the literature [12] . We assumed the lowest mean SpO 2 to be 93% in the Excluded (n = 3) (anaesthesia changed from GA-RSI) Not meeting inclusion criteria (n = 1) (BMI>35) Declined to participate (n = 0) Other reasons (n = 6) (consent not possible due to language barrier (3) or confusion (1), prior participation in the study (1 ), could not sign consent because of disability (1) control group and 95% in the treatment group with a SD of 3%. Using a type-1 error of 5% and type-2 error of 20% (power 80%), a sample size of 39 patients in each group was calculated. We therefore included 80 patients in total. Numerical variables were analysed using a independent samples t-test or the Mann-Whitney U-test. Categorical variables were compared using the Pearson Chi-square test. The primary outcome variable, lowest SpO 2 during intubation, was not normally distributed and a non-parametric test, the Mann-Whitney U-test, was used. A value of p < 0.05 was considered statistically significant. The data were analysed using SPSS Statistics software version 24 (IBM, Armonk, NY, USA).
Results
Ninety patients were assessed for eligibility in the study; ten patients were not included (Fig. 1) . Eighty patients were included (Table 1) . One patient was excluded due to protocol violation; accidental manual ventilation during induction. Data from 79 patients were therefore analysed. One patient pre-oxygenated with a facemask desaturated to 93% during laryngoscopy when manual ventilation was undertaken. Data from this patient are included in the analysis. There were no differences in patient characteristics between the two groups ( Table 1 ). The SpO 2 at the end of pre-oxygenation was 100% in both groups.
The combination or dosage of drugs given during induction of anaesthesia did not differ between groups. Kabi AB, Uppsala, Sweden). Sixteen vs. 14 patients in the facemask group and THRIVE group, respectively, received rocuronium, and the rest succinylcholine. Characteristics of the airway and conditions at intubation are presented in Table 2 . No difference in difficulty of intubation was seen.
The primary outcome, median lowest SpO 2 during intubation, until 1 min after the tracheal tube was sited, was 99% (97-100 [70-100]%) for the facemask group and 99% (99-100 [96-100]%) for the THRIVE group ( Fig. 2 ; p = 0.097). However, five patients (12.5%) in the group pre-oxygenated with a facemask desaturated below 93% vs. none in the THRIVE group, (p = 0.019; Fig. 3 ). In fact, no patient pre-oxygenated with THRIVE desaturated below 96%, whereas seven patients pre-oxygenated with a facemask desaturated below this level. The change in level of oxygen saturation (ΔSpO 2 ) from the end of pre-oxygenation until 1 min after intubation was different. Visual inspection of the pharynx for signs of regurgitation while intubating was done. No regurgitation of gastric content was seen in any of the patients in the study.
Discussion
Although we found no difference in the lowest SpO 2 between THRIVE and facemask pre-oxygenation in adults undergoing RSI, there was a lower incidence of patients desaturating below 93% in the group preoxygenated with THRIVE. This last statistic indicates that THRIVE may prevent hypoxia when apnoea is prolonged due to difficulty with intubation.
A number of studies have shown a benefit for oxygen administered with nasal prongs or a pharyngeal catheter during intubation at flows varying from, 3-15 l.min À1 [7] [8] [9] 12] . This was demonstrated as an increased time to desaturation in patients presenting for elective surgery [7] [8] [9] or a decreased incidence of desaturation during emergency intubation [12, 23] , as well as in the critically ill [24] . This has been further developed in the THRIVE concept, where we and others have demonstrated that anaesthetised patients can be oxygenated for an extended time period despite apnoea [13, 14] . In contrast to the study by Mir et al. [16] , we measured SpO 2 as the main outcome variable instead Figure 2 Boxplot comparing the lowest SpO 2 achieved, until 1 min after tracheal intubation, when preoxygenated with facemask (n = 39) or THRIVE (n = 40). The dark horizontal bar represents the median, the edges of the box show the interquartile range (IQR) and the whiskers the lower quartile, except outliers.
Outlier points are also shown.
of PaO 2 . Although we found no difference in the primary outcome, we did establish a difference between the groups in the proportion of patients who desaturated below the pre-defined limit of 93%. This indicates that THRIVE might offer superior conditions for pre-oxygenation compared with the traditional facemask. Apnoeic oxygenation using THRIVE has been shown to generate a slower increase in arterial CO 2 over time suggesting that it provides partial washout of CO 2 [13, 14] . This may be of clinical importance if apnoea is prolonged. However, the ETCO 2 level after intubation did not differ between the groups in our study, which is in line with the study by Mir et al., possibly due to the short apnoea time [16] .
There has been concern about regurgitation of gastric contents when using THRIVE for RSI anaesthesia in emergency surgery patients, since the high oxygen flow may generate positive airway pressure. The nasopharyngeal airway pressure increases by approximately 1 cmH 2 O per 10 l.min À1 of flow [25] . That could, in theory, induce inflation of the stomach, thereby increasing the risk of regurgitation of gastric contents. Ventilating an anaesthetised patient using a facemask with a positive pressure above 14 cmH 2 O has been shown to cause gastric insufflation [26, 27] . In three out of 16 patients, detection of gastric insufflation with ultrasound of the antrum was seen when manually ventilating with a pressure of 10 cmH 2 O [28] . Based on the above, it seems unlikely that an even lower positive pressure of about 7 cmH 2 O, at a flow of 70 l.min
À1
, would cause gastric distension. In this study, of 80 patients undergoing RSI of anaesthesia for emergency surgery, no signs of regurgitation were detected.
There are a number of limitations of our study. The study was carried out during daytime only, which made it possible to follow a strict RSI protocol. In turn, however, this restriction may have preselected a different patient population from those presenting during nights and weekends, which might have affected the outcome.
The overall number of patients desaturating was lower than expected. It is possible that the incidence of desaturation is higher during on-call hours, partly due to lower staffing and a variable level of expertise in airway management. We chose a pre-defined level of desaturation of 93% which is a higher cut-off than in other studies from Europe but consistent with standards from other parts of the world [12, 29] . Moreover, we did not instruct the patients to close their mouth during THRIVE pre-oxygenation, which means that arterial partial pressure of O 2 might have been lower in the THRIVE group compared with the facemask group [30] . Furthermore, the study was not blinded.
It could be argued that choosing RSI as a setting to investigate the efficacy of THRIVE is not ideal. In RSI, the goal is rapidly to secure the airway, whereas THRIVE is designed for periods of prolonged apnoea. However, a method that maintains Figure 3 For each subject, the lowest SpO 2 attained vs. the apnoea time is plotted for (a) facemask and (b) THRIVE pre-oxygenation. oxygenation better, or in a higher proportion of patients, is likely to be beneficial if apnoea is unexpectedly prolonged, as during unanticipated problems with intubation as might arise during RSI. We have shown that THRIVE, providing continued oxygenation rather than just pre-oxygenation, has potential in this regard during RSI.
